Thursday, November 6 - The Umstead Hotel

5:45 p.m.Reception
7:15 p.m.Dinner
Presentation of The Dr. Charles A. Sanders Life Sciences Award
Recognition of new CEO Roundtable on Cancer members and newly accredited CEO Cancer Gold Standard organizations

Friday, November 7 - SAS Executive Briefing Center

7:00 a.m.Breakfast and Registration
Bus service available at 6:45 a.m. from The Umstead to the SAS Executive Briefing Center
8:30 a.m.Welcome and Introduction of New Members
Christopher A. Viehbacher
Chairman, CEO Roundtable on Cancer
President of the EFPIA, European Federation of Pharmaceutical Industries and Associations
8:40 a.m.CEO’s Report
Martin J. Murphy, Jr., Ph.D., DMedSc, FASCO
Chief Executive Officer and Co-Founder, CEO Roundtable on Cancer
8:45 a.m.Nominating Committee Report
Robert A. Ingram, Hatteras Venture Partners
Past Chairman and Co-Founder, CEO Roundtable on Cancer
8:50 a.m. Chairman’s Remarks
Christopher A. Viehbacher
9:00 a.m.Life Sciences Consortium Task Force Report
Mace L. Rothenberg, M.D., Pfizer
Co-Chairs Life Sciences Consortium Task Force
Gregory A. Curt, M.D., AstraZeneca
Charles Hugh-Jones, M.D., FRCP, Sanofi
10:00 a.m.CEO Roundtable Photo and Break
10:30 a.m.CEO Cancer Gold Standard Task Force Report
Fikry W. Isaac, M.D., MPH, FACOEM, Johnson & Johnson
Judy O’Hagan, Sanofi US
Co-Chairs, CEO Cancer Gold Standard Task Force
11:00 a.m.

Chairman’s Advisory Council
Panel Discussion: Project Data Sphere & CEO Roundtable on Cancer – China

Christopher A. Viehbacher, Chair

David R. Brennan, Retired Chief Executive Officer, AstraZeneca

Dennis B. Gillings, Executive Chairman, Quintiles

Jim Goodnight, Chief Executive Officer, SAS

Robert A. Ingram, General Partner, Hatteras Venture Partners

Martin J. Murphy, Ph.D., DMedSc, FASCO, CEO and Co-Founder, CEO Roundtable on Cancer

William C. Weldon, Former Chairman of the Board and Chief Executive Officer, Johnson & Johnson

11:45 a.m.Chairman’s Closing Remarks and Adjournment
Christopher A. Viehbacher
12:00 - 1:00 p.m.
Buffet Lunch and Adjournment

SAS logo

SAS is a tobacco-free campus and is proud to support the CEO Roundtable on Cancer – XIII.
Video and podcasts will be available post-meeting. Release forms will be provided at the meeting.

 

Back to Top